Literature for peptidase C01.013: cathepsin X

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(References are filtered for relevance to Inhibitor. To remove the filter click here. See explanation.)

    2020
  1. Fonovic,U.P., Knez,D., Hrast,M., Zidar,N., Proj,M., Gobec,S. and Kos,J.
    Structure-activity relationships of triazole-benzodioxine inhibitors of cathepsin X
    Eur J Med Chem193, 112218-112218. PubMed  Europe PubMed DOI  I
  2. Mountford,S.J., Anderson,B.M., Xu,B., Tay,E.S.V., Szabo,M., Hoang,M.L., Diao,J., Aurelio,L., Campden,R.I., Lindstrom,E., Sloan,E.K., Yates,R.M., Bunnett,N.W., Thompson,P.E. and Edgington-Mitchell,L.E.
    Application of a sulfoxonium ylide electrophile to generate cathepsin X-selective activity-based probes
    ACS Chem Biol15, 718-727. PubMed  Europe PubMed DOI  I
  3. 2017
  4. Fonovic,U.P., Mitrovic,A., Knez,D., Jakos,T., Pislar,A., Brus,B., Doljak,B., Stojan,J., Zakelj,S., Trontelj,J., Gobec,S. and Kos,J.
    Identification and characterization of the novel reversible and selective cathepsin X inhibitors
    Sci Rep7, 11459-11459. PubMed  Europe PubMed DOI  I
  5. Pislar,A., Bozic,B., Zidar,N. and Kos,J.
    Inhibition of cathepsin X reduces the strength of microglial-mediated neuroinflammation
    Neuropharmacology114, 88-100. PubMed  Europe PubMed DOI  I
  6. 2013
  7. Pecar Fonovic,U., Jevnikar,Z., Rojnik,M., Doljak,B., Fonovic,M., Jamnik,P. and Kos,J.
    Profilin 1 as a target for cathepsin X activity in tumor cells
    PLoS ONE8, e53918-e53918. PubMed  Europe PubMed DOI  I
  8. Skvarc,M., Stubljar,D., Kopitar,A.N., Jeverica,S., Tepes,B., Kos,J. and Ihan,A.
    Inhibition of cathepsin X enzyme influences the immune response of THP-1 cells and dendritic cells infected with Helicobacter pylori
    Radiol Oncol47, 258-265. PubMed  Europe PubMed DOI  I
  9. 2001
  10. Menard,R., Therrien,C., Lachance,P., Sulea,T., Qo,H., Alvarez-Hernandez,A.D. and Roush,W.R.
    Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design
    Biol Chem382, 839-845. PubMed  Europe PubMed DOI  I
  11. [YEAR:6-3-2001]Therrien,C., Lachance,P., Sulea,T., Purisima,E.O., Qi,H., Ziomek,E., Alvarez-Hernandez,A., Roush,W.R. and Menard,R.
    Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities
    Biochemistry40, 2702-2711. PubMed  Europe PubMed DOI  I
  12. 2000
  13. Klemencic,I., Carmona,A.K., Cezari,M.H.S., Juliano,M.A., Juliano,L., Guncar,G., Turk,D., Krizaj,I., Turk,V. and Turk,B.
    Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase
    Eur J Biochem267, 5404-5412. PubMed  Europe PubMed DOI  I